Michael Shaw Murphey Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 470-732-4000 |
News Archive
Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Multiple myeloma is a plasma cell cancer that is more common in patients of African American descent than of European American descent.
Compared with ipilimumab, treatment with pembrolizumab not only significantly improves outcomes, but also results in fewer high-grade adverse events in patients with advanced melanoma, a phase III trial shows.
Indications are the Supreme Court's much-anticipated ruling on the health law may come on Wednesday or Thursday. However, the court is also scheduled to hand down decisions on Monday.
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.
› Verified 9 days ago